Title : Small cell transformation in crizotinib-resistant ROS1-rearranged non-small cell lung cancer with retention of ROS1 fusion: A case report.

Pub. Date : 2021 Nov

PMID : 34623764






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Small cell transformation in crizotinib-resistant ROS1-rearranged non-small cell lung cancer with retention of ROS1 fusion: A case report. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens
2 Here, we present the case of a 63-year-old man with ROS1-rearranged advanced NSCLC who had disease progression with small cell transformation of the mediastinal lymph node after 8 months of treatment with crizotinib. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens